Verified· 2 sources

ArcoScreen SA

Summary

About the company

The core activity of Arcoscreen SA is the development and application of an innovative technology for GPCR primary cell screening, to support pharmaceutical companies in identifying promising G-protein-coupled receptor (GPCR) compounds in primary cells. This includes providing services such as identifying the mechanism of action of drugs in primary cells, activating GPCRs, and developing stable cell lines.

AI-generated

Offering

Products & services

Industry:Research & Development

✓ Offered3

Gα activation

Identification of the molecular mode of action in primary cells, including determination of the implicated Gα subunits, EC50 and IC50 values, 384-well microfluidic plate format.

GTPγS activation

Activation of GPCRs in primary or mammalian cells, including determination of dose-response curves, EC50 and IC50 values, 384-well microfluidic plate format.

Arcoflow platform

Primary cell screening platform combining a biological assay and a microfluidic device to identify the molecular mode of action of compounds.

Outbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub

ArcoScreen SA

About the company

Products & services

Looking for direct email addresses and phone numbers?

ArcoScreen SA

About the company

Products & services

Looking for direct email addresses and phone numbers?

No knowledge articles yet

ArcoScreen SA in comparison

Industry comparisons are coming soon

Similar companies